Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

related to degree

  • Shi, Cindy Jun, Ph.D. in Chemistry, Scripps Research 2006 - 2011

authors

  • Porter, D. C.
  • Farmaki, E.
  • Altilia, S.
  • Schools, G. P.
  • West, D. K.
  • Chen, M. Q.
  • Chang, B. D.
  • Puzyrev, A. T.
  • Lim, C. U.
  • Rokow-Kittell, R.
  • Friedhoff, L. T.
  • Papavassiliou, A. G.
  • Kalurupalle, S.
  • Hurteau, G.
  • Shi, Cindy Jun
  • Baran, Phil
  • Gyorffy, B.
  • Wentland, M. P.
  • Broude, E. V.
  • Kiaris, H.
  • Roninson, I. B.

publication date

  • August 2012

journal

  • Proceedings of the National Academy of Sciences of the United States of America  Journal

abstract

  • Conventional chemotherapy not only kills tumor cells but also changes gene expression in treatment-damaged tissues, inducing production of multiple tumor-supporting secreted factors. This secretory phenotype was found here to be mediated in part by a damage-inducible cell-cycle inhibitor p21 (CDKN1A). We developed small-molecule compounds that inhibit damage-induced transcription downstream of p21. These compounds were identified as selective inhibitors of a transcription-regulating kinase CDK8 and its isoform CDK19. Remarkably, p21 was found to bind to CDK8 and stimulate its kinase activity. p21 and CDK8 also cooperate in the formation of internucleolar bodies, where both proteins accumulate. A CDK8 inhibitor suppresses damage-induced tumor-promoting paracrine activities of tumor cells and normal fibroblasts and reverses the increase in tumor engraftment and serum mitogenic activity in mice pretreated with a chemotherapeutic drug. The inhibitor also increases the efficacy of chemotherapy against xenografts formed by tumor cell/fibroblast mixtures. Microarray data analysis revealed striking correlations between CDK8 expression and poor survival in breast and ovarian cancers. CDK8 inhibition offers a promising approach to increasing the efficacy of cancer chemotherapy.

subject areas

  • Animals
  • Antineoplastic Agents
  • Cell Aging
  • Cell Line, Tumor
  • Cell Nucleolus
  • Cyclin-Dependent Kinase 8
  • Cyclin-Dependent Kinase Inhibitor p21
  • Gene Expression Regulation, Neoplastic
  • Genomics
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Transplantation
  • Neoplasms
  • Oligonucleotide Array Sequence Analysis
  • Promoter Regions, Genetic
  • S-Phase Kinase-Associated Proteins
  • Transcription, Genetic
  • Treatment Outcome
scroll to property group menus

Research

keywords

  • chemical genomics
  • nucleolus
  • senescence
  • transcriptional damage response
  • tumor microenvironment
scroll to property group menus

Identity

PubMed Central ID

  • PMC3427077

International Standard Serial Number (ISSN)

  • 0027-8424

Digital Object Identifier (DOI)

  • 10.1073/pnas.1206906109

PubMed ID

  • 22869755
scroll to property group menus

Additional Document Info

start page

  • 13799

end page

  • 13804

volume

  • 109

issue

  • 34

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support